Financial News
AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )
1.100
-0.010
(-0.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about AN2 Therapeutics, Inc. - Common Stock
![](https://mms.businesswire.com/media/20231010060919/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
October 11, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230926590651/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230913252729/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/06/image10.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/23/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
August 17, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230815851416/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230810314462/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230525005314/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230510006124/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230501005119/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230328005954/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230228006237/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
AN2 Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230131005415/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/01/27/image13.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image-lennar.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 02, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
October 19, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/10/12/image-uber.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/244a98ea-f1aa-4e63-a545-015333e9d8dd/small/an2-therapeutics-logo-weba-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/image_1.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/244a98ea-f1aa-4e63-a545-015333e9d8dd/small/an2-therapeutics-logo-weba-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17903.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16770.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/07/image46.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.